Glibenclamide therapy: pros and cons
The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibe...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/176cc5d7a32949878807dfda4fd62a37 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:176cc5d7a32949878807dfda4fd62a37 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:176cc5d7a32949878807dfda4fd62a372021-11-14T09:00:16ZGlibenclamide therapy: pros and cons2072-03512072-037810.14341/2072-0351-6231https://doaj.org/article/176cc5d7a32949878807dfda4fd62a372011-09-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/6231https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibenclamide, but not other SU (gliclazide or glimepiride)Olga Konstantinovna VikulovaMarina Vladimirovna ShestakovaEndocrinology Research Centrearticlediabetes mellitus type 2glibenclamidehypoglysemiamortalityNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 14, Iss 3, Pp 92-96 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
diabetes mellitus type 2 glibenclamide hypoglysemia mortality Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
diabetes mellitus type 2 glibenclamide hypoglysemia mortality Nutritional diseases. Deficiency diseases RC620-627 Olga Konstantinovna Vikulova Marina Vladimirovna Shestakova Glibenclamide therapy: pros and cons |
description |
The safety of antidiabetic medications has received much attention in the resent past. Although concerns on the safety of glibenclamide therapy iscontroversial, some studies showed an increased risk of cardiovascular morbidity (f.e. myocardial infarction) and risk of mortality in subjects usingglibenclamide, but not other SU (gliclazide or glimepiride) |
format |
article |
author |
Olga Konstantinovna Vikulova Marina Vladimirovna Shestakova |
author_facet |
Olga Konstantinovna Vikulova Marina Vladimirovna Shestakova |
author_sort |
Olga Konstantinovna Vikulova |
title |
Glibenclamide therapy: pros and cons |
title_short |
Glibenclamide therapy: pros and cons |
title_full |
Glibenclamide therapy: pros and cons |
title_fullStr |
Glibenclamide therapy: pros and cons |
title_full_unstemmed |
Glibenclamide therapy: pros and cons |
title_sort |
glibenclamide therapy: pros and cons |
publisher |
Endocrinology Research Centre |
publishDate |
2011 |
url |
https://doaj.org/article/176cc5d7a32949878807dfda4fd62a37 |
work_keys_str_mv |
AT olgakonstantinovnavikulova glibenclamidetherapyprosandcons AT marinavladimirovnashestakova glibenclamidetherapyprosandcons |
_version_ |
1718429572579459072 |